EXEL Competitors & Alternatives
Compare Exelixis Inc with similar stocks in the same industry
Biotechnology
EXEL
Main Stock$51.50
Tradestie Score
60
Market Cap
$11.09B
P/E Ratio
17.2
Revenue Growth
0.1%
Analyst Upside
-4.9%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$54.92
|
$15.70B | 27.9 | 60 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$14.29
|
$15.22B | - | 50 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$160.65
|
$13.59B | 24.3 | 60 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$237.15
|
$12.36B | 26.4 | 55 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$31.98
|
$10.76B | - | 63 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$61.41
|
$10.74B | - | 60 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$56.95
|
$10.53B | 39.3 | 65 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$76.25
|
$10.49B | - | 64 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$68.74
|
$10.22B | - | 65 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$512.94
|
$10.01B | - | 60 | Compare |
More EXEL Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry